article thumbnail

Logistics in Focus: Orchestrating the Challenges of Cell Therapy

Worldwide Clinical Trials

Despite their exciting potential, the smooth operation of cell therapy development trials requires extraordinary orchestration, perfectly aligning the product and patient journeys. While clinical supply is essential to any successful trial, autologous cell therapy trials occupy the far end of the spectrum regarding risk tolerance.

article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Autologous therapies are characterized as a circular supply chain; the patient’s own sample starts the supply chain, and it is then subjected to ex-vivo modifications with the resulting therapy administered back to that same patient. CGT trials operate with much lower volumes of manufactured final product.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sharp completes new gene therapy packaging and distribution capacity in The Netherlands

BioPharma Reporter

Contract packaging and clinical supply services company Sharp has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies at its facility in Heerenveen, The Netherlands.

article thumbnail

Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development

The Pharma Data

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational advanced therapy products by minimizing their time-out-of-environment. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year.

article thumbnail

[Webinar] How biotech companies can improve clinical supply planning and distrib…

The Pharma Data

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

article thumbnail

 MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a.

BioTech 365

MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a. MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a. Monrol Nuclear Products Co. WEST CHESTER, Pa. & & ISTANBUL–(BUSINESS WIRE)–#Lutetium–Eczac?ba??-Monrol

article thumbnail

NUCLIDIUM and PharmaLogic partner to develop copper-based theranostics in US

Pharmaceutical Technology

NUCLIDIUM has signed a strategic collaboration deal with PharmaLogic for the manufacturing and clinical supply of copper-based theranostics ⁶¹Cu in the US. ⁶¹Cu It will also enable NUCLIDIUM to achieve a sustainable supply of ⁶¹Cu in the US for its proposed clinical trials and upcoming commercialised products.